Determination of metabolite concentrations in human brain tumour biopsy samples using HR-MAS and ERETIC measurements

NMR in Biomedicine

Volumn 22, Issue 2, 2009, Pages 199-206

  Martínez Bisbal, M Carmen ^a,b   Monleon, Daniel ^c   Assemat, Olivier ^d   Piotto, Martial ^d   Piquer, José ^e   Llácer, José Luis ^e   Celda, Bernardo ^a,b  

^a BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^d Bruker Corporation   (United States)

^e Hospital Universitario de la Ribera   (Spain)

Author keywords

Biopsies; Brain tumours; ERETIC ; High resolution magic angle spinning (HR MAS); Metabolite concentration

Indexed keywords

BIOLOGICAL SAMPLES; BIOPSY SAMPLES; BRAIN TUMOURS; CONCENTRATION OF; EX-VIVO; GLIOBLASTOMA MULTIFORME; HIGH RESOLUTION MAGIC ANGLE SPINNING; HIGH-RESOLUTION MAGIC ANGLE SPINNING (HR-MAS); HUMAN BRAIN; IN-VITRO; IN-VIVO; INTERNAL STANDARD METHOD; METABOLITE CONCENTRATION; METABOLITE CONCENTRATIONS; MODEL SOLUTION; ONE-DIMENSIONAL; SALT CONCENTRATION; SAMPLE PREPARATION; SODIUM SALT; SPECTRAL QUALITY; TUMOURS;

BIOMOLECULES; BIOPSY; HISTOLOGY; METABOLISM; METABOLITES; ONCOLOGY; TRANSPLANTS; TUMORS;

CONCENTRATION (PROCESS);

ACETIC ACID; ALANINE; CHOLINE; CREATINE; DOCUSATE SODIUM; GLUTAMIC ACID; GLUTAMINE; GLYCEROPHOSPHORYLCHOLINE; LACTIC ACID; N ACETYLASPARTIC ACID; PHOSPHORYLCHOLINE; DIAGNOSTIC AGENT; PROTON; TUMOR MARKER; TUMOR PROTEIN;

ACCURACY; ARTICLE; BRAIN METABOLISM; CANCER SURGERY; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ELECTRONIC REFERENCE TO IN VIVO CONCENTRATION; EX VIVO STUDY; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INSTRUMENT VALIDATION; INTERMETHOD COMPARISON; METABOLITE; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTON HIGH RESOLUTION MAGIC ANGLE SPINNING NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; TISSUE PREPARATION; TUMOR BIOPSY; ALGORITHM; BRAIN TUMOR; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY;

ALGORITHMS; BRAIN NEOPLASMS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; NEOPLASM PROTEINS; PROTONS; TUMOR MARKERS, BIOLOGICAL;

EID: 64549112729     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1304     Document Type: Article

References (29)

1. Cheng LL, Ma MJ, Becerra L, Ptak T, Tracey I, Lackner A, Gonzalez RG. Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. Proc Natl Acad Sci USA. 1997; 94: 6408-6413.
2. Cheng LL, Chang I-W, Louis DN, Gonzalez RG. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. Cancer Res. 1998; 58: 1825-1832.
3. Cheng LL, Anthony DC, Comite AR, Black PM, Tzika AA, Gonzalez RG. Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopy. Neuro-oncology. 2000; 2: 87-95.
4. Tzika AA, Cheng LL, Goumnerova L, Madsen JR, Zurakowski D, Astrakas LG, Zarifi MK, Scott RM, Anthony DC, Gonzalez RG, Black PM. Biochemical characterization of pediatric brain tumors by using in vivo and ex vivo magnetic resonance spectroscopy. J. Neurosurg. 2002; 96: 1023-1031.
5. 1H MRS study of human high grade gliomas. NMR Biomed. 2004; 17: 191-205.
6. Cheng LL, Chang I-W, Smith BL, Gonzalez RG. Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy. J. Magn Reson. 1998; 135: 194-202.
7. Sitter B, Sonnewald U, Spraul M, Fjösne HE, Gribbestad IS. High-resolution magic angle spinning MRS of breast cancer tissue. NMR Biomed. 2002; 15: 327-337.
8. Sitter B, Lundgren S, Bathen TF, Halgunset J, Fjosne HE, Gribbestad IS. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters. NMR Biomed. 2006; 19: 30-40.
9. 1H NMR spectroscopy of intact liver tissue. Magn Reson Med. 2003; 50: 925-930.
10. 1H NMR spectroscopy. NMR Biomed. 2006; 19: 90-100.
11. 1H NMR spectroscopy at 9.4 T. FEBS Lett. 2001; 494: 112-116.
12. Swanson MG, Vigneron DB, Tabatabai ZL, Males RG, Schmitt L, Carroll PR, James JK, Hurd RE, Kurhanewicz J. Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted post-surgical prostate tissues. Magn Reson Med. 2003; 50: 944-954.
13. Taylor JL, Wu CL, Cory D, Gonzalez RG, Bielecki A, Cheng LL. High-resolution magic angle spinning proton NMR analysis of human prostate tissue with slow spinning rates. Magn Reson Med. 2003; 50: 627-632.
14. Burns MA, Taylor JL, Wu C-L, Zepeda AG, Bielecki A, Cory D, Cheng LL. Reduction of spinning sidebands in proton NMR of human prostate tissue with slow high-resolution magic angle spinning. Magn Reson Med. 2005; 54: 34-42.
15. 1H HR-MAS spectroscopy. Magn Reson Med. 2006; 55: 1257-1264
16. Mahon MM, de Souza NM, Dina R, Soutter WP, McIndoe GA, Williams AD, Cox IJ. Preinvasive and invasive cervical cancer: an ex vivo proton magic angle spinning magnetic resonance spectroscopy study. NMR Biomed. 2004; 17: 144-1532.
17. Millis K, Weybright P, Campbell N, Fletcher JA, Fletcher CD, Cory DG, Singer S. Classification of human liposarcoma and lipoma using ex vivo proton NMR spectroscopy. Magn Reson Med. 1999; 41: 257-267.
18. Kriat M, Confort-Gouny S, Vion-Dury J, Sciaky M, Viout P, Cozzone PJ. Quantitation of metabolites in human blood serum by proton magnetic resonance spectroscopy. A. comparative study of the use of formate and TSP as concentration standards. NMR Biomed. 1992; 5: 179-184.
19. Barantin L, LePape A, Akoka S. A new method for absolute quantitation of MRS metabolites. Magn Reson Med. 1997; 38: 179-182.
20. Akoka S, Barantin L, Trierweiler M. Concentration measurement by proton NMR using the ERETIC method. Anal Chem. 1999; 71: 2554-2557.
21. 1H NMR ERETIC method. Carbohyd Res. 2006; 341: 1890-1895.
22. Ziarelli F, Caldarelli S. Solid-state NMR as an analytical tool: quantitative aspects. Solid State Nuclear Magnetic Resonance. 2006; 29: 214-218.
23. Levin VA, Leibel SA, Gutin PH. Neoplasms of the central nervous system. In Cancer Principles and Practice of Oncology, Vol. 2, 5th edn. De Vita VT Jr, Hellman S, Rosenberg SA (eds). Lippincott-Raven: Philadelphia, 1997; 2022-2081.
24. Dillmann B, Elbayed K, Zeiger H, Weingertner M-C, Piotto M, Engelke F. A novel low-E field coil to minimize heating of biological samples in solid-state multinuclear NMR experiments. J. Magn Reson. 2007; 187: 10-18.
25. Isobe T, Matsumura A, Anno I, Yoshizawa T, Nagatomo Y, Itai Y, Nose T. Quantification of cerebral metabolites in glioma patients with proton MR spectroscopy using T2 relaxation time correction. Magn Reson Imaging. 2002; 20: 343-349.
26. Tong Z, Yamaki T, Harada K, Houkin K. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard. Magn Reson Imaging. 2004; 22: 1017-1024.
27. 1H magnetic resonance spectroscopy. Magn Reson Med. 2003; 49: 223-232.
28. 1H MR spectra: a comparison of classification using whole spectra versus metabolite quantification. NMR Biomed. 2007; in press.
29. Kinoshita Y, Yokota A. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. NMR Biomed. 1997; 10: 2-12.